Hypersensitivity Pneumonitis clinical trials at UC Davis

1 in progress, 0 open to eligible people

Prognostic Transcriptomic Signature for Chronic Hypersensitivity Pneumonitis
Sorry, in progress, not accepting new patients
Up to 150 patients with hypersensitivity pneumonitis will be enrolled at 7 clinical centers across the United States. Patients will be followed for 24 months to determine if biomarkers in the blood can predict disease progression.
Sacramento, California and other locations

Last updated: April 6, 2026